2024

1. A genome-wide association study of adults with community-acquired pneumonia

   Respiratory Research, Vol. 25, Núm. 1

2. Association study of human leukocyte antigen variants and idiopathic pulmonary fibrosis

   ERJ Open Research, Vol. 10, Núm. 1

3. Biomarkers in Alzheimer’s Disease: Are Olfactory Neuronal Precursors Useful for Antemortem Biomarker Research?

   Brain Sciences, Vol. 14, Núm. 1

4. Changes in AmotL2 Expression in Cells of the Human Enteral Nervous System in Oxaliplatin-Induced Enteric Neuropathy

   Biomedicines, Vol. 12, Núm. 9

5. Dorsal root ganglion inflammation by oxaliplatin toxicity: DPEP1 as possible target for peripheral neuropathy prevention

   BMC Neuroscience, Vol. 25, Núm. 1

6. Erratum: Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19 (Genome medicine (2023) 15 1 (22))

   Genome medicine

7. Evaluation of clinical events and costs associated with the addition of dapagliflozin to chronic kidney disease treatment: Cost offset analysis

   Nefrologia

8. Exploring the Anticancer Potential of Phenolic nor-Triterpenes from Celastraceae Species

   International Journal of Molecular Sciences, Vol. 25, Núm. 17

9. FGF23 as a Potential Pathophysiological Factor in Peripheral Arterial Disease Associated with Chronic Kidney Disease

   International Journal of Molecular Sciences, Vol. 25, Núm. 10

10. Genomic epidemiology of the primary methicillin-resistant Staphylococcus aureus clones causing invasive infections in Paraguayan children

    Microbiology Spectrum, Vol. 12, Núm. 4

11. Modelling the demographic history of human North African genomes points to a recent soft split divergence between populations

    Genome Biology, Vol. 25, Núm. 1

12. Msc1 is a nuclear envelope protein that reinforces DNA repair in late mitosis

    iScience, Vol. 27, Núm. 7

13. Novel risk loci for COVID-19 hospitalization among admixed American populations

    eLife, Vol. 13

14. Osteoporosis management in patients with chronic kidney disease (ERCOS Study): A challenge in nephrological care

    Nefrologia , Vol. 44, Núm. 2, pp. 241-250

15. Pentoxifylline ameliorates subclinical atherosclerosis progression in patients with type 2 diabetes and chronic kidney disease: a randomized pilot trial

    Cardiovascular Diabetology, Vol. 23, Núm. 1

16. Projection of the clinical and economic burden of chronic kidney disease between 2022 and 2027 in Spain: Results of the Inside CKD project

    Nefrologia

17. Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir

    Alimentary Pharmacology and Therapeutics, Vol. 60, Núm. 2, pp. 201-211

18. Risk factors for progression in KDOQI stage 3 Chronic Kidney Disease (PROGRESER study)

    Nefrologia, Vol. 44, Núm. 5, pp. 689-699

19. Transcriptome-Wide Association Study of Idiopathic Pulmonary Fibrosis Survival Identifies PTPN9 and SNRPB2

    American journal of respiratory and critical care medicine

20. Worldwide distribution of genetic factors related to severity of COVID-19 infection

    Annals of Human Biology, Vol. 51, Núm. 1